SABR Clinical Trials
7 recruitingRadiation
Not Applicable4Phase 23Phase 11
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
Borderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic AdenocarcinomaLocalized Pancreatic Adenocarcinoma
Amsterdam UMC, location VUmc66 enrolled4 locationsNCT06384560
Recruiting
Not Applicable
Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management
Breast Cancer Female
University of Kansas Medical Center18 enrolled2 locationsNCT07242118
Recruiting
Phase 2
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Advanced Colorectal CarcinomaImmunotherapy
Fudan University208 enrolled10 locationsNCT06521866
Recruiting
Not Applicable
Low and Intermediate Risk OliGometastatic ColoREctal CancEr PatieNts Treated with Stereotactic ABlative Radiotherapy
IRCCS Sacro Cuore Don Calabria di Negrar204 enrolled1 locationNCT06310564
Recruiting
Not Applicable
Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases
Solid TumorSpinal TumorSpinal Neoplasms
Cancer Research Antwerp128 enrolled9 locationsNCT06613295
Recruiting
Phase 2
Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer
Lung Cancer Metastatic
Centre hospitalier de l'Université de Montréal (CHUM)68 enrolled1 locationNCT04405401
Recruiting
Not Applicable
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
Breast Cancer Stage IVOligometastatic Disease
Vastra Gotaland Region345 enrolled1 locationNCT05377047